Swine flu: Lessons we need to learn from our global experience

Emerging Health Threats Journal

Volumn 4, Issue 1, 2011, Pages

  Collignon, Peter ^a,b  

^a CANBERRA HOSPITAL   (Australia)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

Anti viral therapy; H1N1; Influenza; Pandemic response; Swine flu; Vaccination

Indexed keywords

COMMUNITY CARE; COST BENEFIT ANALYSIS; EXPERIENCE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE PRACTICE; HOSPITAL CARE; HUMAN; INFLUENZA VIRUS A H1N1; INTENSIVE CARE UNIT; LEARNING; MEXICO; NOTE; PANDEMIC INFLUENZA; SEASONAL INFLUENZA; SWINE INFLUENZA; UNITED STATES; VIRUS STRAIN; VIRUS VIRULENCE; WOMEN'S HEALTH;

EID: 80052738693     PISSN: 17528550     EISSN: 17528550     Source Type: Journal    
DOI: 10.3402/ehtj.v4i0.7169     Document Type: Note

References (31)

1. Centers for Disease Control and Prevention (CDC). Hospitalized patients with novel influenza A (H1N1) virus infection- California, April-May, 2009. MMWR Morb Mortal Wkly Rep. 2009;58:536-41.
2. Collignon P. Swine flu-lessons learnt in Australia. Med J Aust. 2010;192;364-5. Available from: http://www.mja.com.au/public/issues/192_07_050410/col10154_fm.html
3. Kelly HA. A pandemic response to a disease of predominantly seasonal intensity. Med J Aust. 2010;192:81-3. Available from: http://www.mja.com.au/public/issues/192_02_180110/kel11025_fm.html
4. Australian influenza surveillance summary report no. 26, 2009, reporting period: 31 October 2009-6 November 2009. Available from: http://www.healthemergency.gov.au/internet/healthemergency/publishing.nsf/Content/18D06BAC4644C98DCA25763E00823442/SFile/ozflu-no26-2009.pdf
5. Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS, et al. Novel Influenza A (H1N1) Pregnancy Working Group. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet. 2009 Aug 8; 374(9688):451-8.
6. New South Wales public health network. Progression and impact of the first winter wave of the 2009 pandemic H1N1 influenza in New South Wales, Australia. Euro Surveill. 2009; 14(42):pii-19365. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId-19365
7. Morens DM, Taubenberger JK, Fauci AS. The 2009 H1N1 Pandemic Influenza Virus: What Next? MBio. 2010;1(4):pii-e00211-10. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945198/?tool-pubmed
8. Kelly HA, Mercer GN, Fielding JE, Dowse GK, Glass K, Carcione D, et al. Pandemic (H1N1) 2009 Influenza Community Transmission Was Established in One Australian State When the Virus Was First Identified in North America. PLoS ONE. 2010;5(6):e11341. doi:10.1371/journal.pone.0011341
9. Australian Government Department of Health and Ageing. 2009. New pandemic phase-Protect. Available from: http://www.healthemergency.gov.au/internet/healthemergency/publishing.nsf/Content/news-170609
10. Doshi P. Calibrated response to emerging infections. BMJ. 2009;339:b3471. doi: 10.1136/bmj.b3471. Available from: http://www.bmj.com/content/339/bmj.b3471.full
11. Interim Pre-pandemic Planning Guidance: Community Strategy for Pandemic Influenza Mitigation in the United States. February 2007. CDC Atlanta (accessed 2010 February 9). Available from: http://www.flu.gov/professional/community/mitigation.html
12. Australian Institute of Health and Welfare (AIHW). Australian hospital statistics 2008-09. Available from: http://www.aihw.gov.au/publications/hse/84/11173-sum.html
13. Jefferson T, Jones M, Doshi P, Del Mar C, Dooley L, Foxlee R. Neuraminidase inhibitors for preventing and treating influenza in healthy adults. Cochrane Database Syst Rev. 2010 Feb 17;(2): CD001265. Available from: http://www2.cochrane.org/reviews/en/ab001265.html
14. Collignon P. H1N1 immunisation: too much too soon. Aust Prescr. 2010;33:30-1. Available from: http://www.australianprescriber.com/magazine/33/2/30/1/
15. Baguelina M, Van Hoeka A, Jit M, Stefan Flaschea S, White PJ, Edmunds WJ. Vaccination against pandemic influenza A/H1N1v in England: A real-time economic evaluation. Vaccine. 2010 Mar 11;28(12):2370-84.
16. Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, Bennet J, et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med. 2009 Dec 17;361(25):2405-13.
17. Martin D. £1.2bn spent to beat swine flu.. and just 26 lives saved. Mailonline. [accessed 2010 August 3]. http://www.dailymail.co.uk/news/article-1299495/1-2bn-spent-beat-swine-flu-just-26-lives-saved.html June 22, 2011.
18. Australian influenza surveillance report. no. 38, 2010, reporting period: 18 September-24 September 2010. Available from: http://www.healthemergency.gov.au/internet/healthemergency/publishing.nsf/Content/ozflu2010-jul-sep-pdf-cnt.htm/SFile/ozflu-no38-2010.pdf
19. Rosenthal S, Chen R. The reporting sensitivities of two passive surveillance systems for vaccine adverse events. Am J Public Health. 1995;85(12):1706-9. Available from: http://ajph.aphapublications.org/cgi/reprint/85/12/1706
20. Neustadt R, Fineberg H. The swine flu affair. Decision-making on a slippery disease. Washington: U.S. Department of Health, Education, and Welfare; 1978. Available from: http://iom.edu/Global/News%20Announcements/-/media/Files/About%20the%20IOM/SwineFluAffair.pdf June 22, 2011.
21. Professor Bryant Stokes. Final Report to the Minister for Health. July 2010 Ministerial Review into the Public Health Response into the Adverse Events to the Seasonal Influenza Vaccine. [accessed 2010 August 9]. Available from: http://www.health.wa.gov.au/publications/documents/Stokes_Report.pdf
22. Collignon P, Doshi P, Jefferson T. Rapid response. Adverse events following influenza vaccination in Australia-should we be surprised? Available from: www.bmj.com/cgi/eletters/340/may04_2/c2419#235364
23. Bishop J. Seasonal flu vaccine remains suspended for young children without risk factors-Advice from the Chief Medical Officer. Departmental media releases. Australian Government, Department of Health and Ageing. (accessed 2010 June 1). Available from: www.health.gov.au/internet/main/publishing.nsf/Content/mr-yr10-dept-dept010610.htm June 22, 2011.
24. Skowronski DM, De Serres G, Crowcroft NS, Janjua NZ, Boulianne N, Hottes TS, et al. Canadian SAVOIR Team. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada.
25. Kelly H, Grant K. Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination. Eurosurveillance 2009;14. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId-19288
26. Morens DM, Burke DS, Halstead SB. The wages of original antigenic sin. Emerg Infect Dis. 2010;16:1023-4.
27. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness J Infect Dis. 2008;198:962-70.
28. MMWR. Bacterial Coinfections in Lung Tissue Specimens from Fatal Cases of 2009 Pandemic Influenza A (H1N1)-United States, May-August 2009. Early release September 29, 2010. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm58e0929a1.htm
29. Charles PG, Johnson PD, Collignon PJ. Can we readily identify patients who need antibiotics in a severe influenza pandemic? Med J Aust. 2009;191:517-8.
30. Jefferson T, Del Mar C, Dooley L, Ferroni E, Al-Ansary LA, Bawazeer GA, et al. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD006207. Review.
31. Lo JY, Tsang TH, Leung YH, Yeung EY, Wu T, Lim WW. Respiratory infections during SARS outbreak, Hong Kong, 2003. Emerg Infect Dis. 2005 Nov;11(11):1738-41.